Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)
Hepatitis A, Measles, Mumps
About this trial
This is an interventional prevention trial for Hepatitis A
Eligibility Criteria
Inclusion Criteria: Negative clinical history of hepatitis A, measles, mumps, rubella, varicella (chickenpox), and/or zoster No other vaccinations scheduled to be administered at the time of the first or second doses of VAQTA(TM) and ProQuad(TM) Exclusion Criteria: Previously vaccinated with any hepatitis A vaccine, measles, mumps, rubella, and/or varicella vaccine either alone or in any combination History of allergy to any vaccine component History of seizure disorder Immunosuppressed including congenial and acquired conditions and immunosuppressive therapy Known severe thrombocytopenia or any other coagulation disorder that would contraindicate intramuscular injections Recent (<72 hours) febrile illness (>100.3 degrees F [>37.9 degrees C] oral equivalent) prior to study vaccination.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
1
2
Arm 1: vaccine
Arm 2: Active comparator